| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
ACOG
Alpha Cognition Inc
|
Jun 17, 2026 | BUY |
Strong Buy
+117.1% avg upside
3 analysts
|
— | · |
|
DMAC
Diamedica Therapeutics
|
Jun 17, 2026 | BUY |
Strong Buy
+153.7% avg upside
12 analysts
|
— | · |
|
MDXG
MiMedx Group
|
Jun 17, 2026 | BUY |
Strong Buy
+185.0% avg upside
17 analysts
|
— | · |
|
XERS
Xeris Pharmaceuticals
|
Jun 11, 2026 | BUY |
Strong Buy
+33.7% avg upside
10 analysts
|
— | -0.4% |
|
CVRX
CVRx
|
Jun 09, 2026 | BUY |
Strong Buy
+136.7% avg upside
9 analysts
|
— | · |
|
HROW
Harrow Health
|
Jun 08, 2026 | BUY |
Strong Buy
+25.5% avg upside
12 analysts
|
— | +26.7% |
|
INDV
Indivior
|
Jun 04, 2026 | BUY |
Strong Buy
+2.1% avg upside
9 analysts
|
— | +1.3% |
|
CELC
Celcuity
|
Jun 03, 2026 | BUY |
Strong Buy
+40.6% avg upside
16 analysts
|
$171.00
94.84% Upside
|
-1.0% |
|
BVS
Bioventus
|
May 22, 2026 | BUY |
Strong Buy
+41.2% avg upside
8 analysts
|
— | -7.0% |
|
ETON
Eton Pharmaceuticals
|
May 20, 2026 | BUY |
Strong Buy
-21.5% avg upside
8 analysts
|
— | -4.9% |
|
XTNT
Xtant Medical Holdings
|
May 13, 2026 | BUY |
Strong Buy
+1451.0% avg upside
9 analysts
|
— | -4.2% |
|
IRWD
Ironwood Pharma
|
May 13, 2026 | BUY |
Hold
+235.8% avg upside
23 analysts
|
— | -4.3% |
|
PYPD
PolyPid
|
May 11, 2026 | BUY |
Strong Buy
+251.6% avg upside
7 analysts
|
— | +8.8% |
|
NRXS
NeurAxis, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+8.0% avg upside
3 analysts
|
— | -17.8% |
|
KRMD
REPRO-MED Systems
|
May 05, 2026 | BUY |
Strong Buy
+64.8% avg upside
9 analysts
|
— | +1.5% |
|
PHAT
Phathom Pharmaceuticals
|
Apr 28, 2026 | BUY |
Strong Buy
+163.5% avg upside
14 analysts
|
— | -4.0% |
|
BFLY
Butterfly Network
|
Apr 28, 2026 | BUY |
Strong Buy
-37.6% avg upside
7 analysts
|
— | +9.5% |
|
GRCE
Grace Therapeutics
|
Apr 24, 2026 | BUY |
Strong Buy
+153.0% avg upside
9 analysts
|
$4.00
67.97% Upside
|
+1.3% |
|
DCTH
Delcath Systems
|
Apr 22, 2026 | BUY |
Strong Buy
+90.3% avg upside
11 analysts
|
— | +6.6% |
|
FENC
Fennec Pharmaceuticals
|
Apr 22, 2026 | BUY |
Strong Buy
+78.1% avg upside
9 analysts
|
— | +34.4% |
|
MDWD
Mediwound
|
Apr 06, 2026 | BUY |
Strong Buy
+51.9% avg upside
13 analysts
|
— | -13.8% |
|
MYO
Myomo
|
Mar 10, 2026 | BUY |
Strong Buy
+464.7% avg upside
9 analysts
|
$1.10
13.98% Downside
|
+28.9% |
|
BLBD
Blue Bird
|
Nov 20, 2025 | BUY |
Strong Buy
-16.5% avg upside
11 analysts
|
— | +44.5% |
|
SMTC
Semtech
|
Nov 19, 2025 | BUY |
Strong Buy
-9.0% avg upside
24 analysts
|
— | +145.4% |
|
MXL
Maxlinear
|
Oct 20, 2025 | BUY |
Buy
-35.8% avg upside
16 analysts
|
— | +441.6% |
|
OKLO
Oklo Inc
|
Oct 17, 2025 | HOLD |
Strong Buy
+59.4% avg upside
24 analysts
|
— | -62.8% |
|
LGND
Ligand Pharma
|
Oct 09, 2025 | BUY |
Strong Buy
-20.8% avg upside
15 analysts
|
— | +44.3% |
|
INOD
Innodata
|
Oct 08, 2025 | BUY |
Strong Buy
+28.5% avg upside
8 analysts
|
— | +12.7% |
|
KORU
Direxion MSCI Daily South Korea Bull 3X Shares
|
Aug 07, 2025 | BUY |
Strong Buy
1 analyst
|
— | +997.9% |
|
CDLX
Cardlytics
|
Jul 23, 2025 | HOLD |
Hold
+349.7% avg upside
16 analysts
|
— | -82.7% |
|
AEHR
Aehr Test Systems
|
Jul 22, 2025 | BUY |
Strong Buy
-46.2% avg upside
4 analysts
|
— | +477.1% |
|
NEXN
Nexxen International
|
Jul 14, 2025 | BUY |
Strong Buy
+32.5% avg upside
16 analysts
|
— | -13.4% |
|
TRLV
Trulieve Cannabis
|
Feb 26, 2025 | BUY |
Strong Buy
+123.5% avg upside
15 analysts
|
$11.50
13.89% Upside
|
· |
|
RMNI
Rimini Street
|
Feb 05, 2025 | BUY |
Strong Buy
+50.3% avg upside
9 analysts
|
— | +38.9% |
|
OMCL
Omnicell
|
Aug 28, 2024 | BUY |
Strong Buy
+36.0% avg upside
12 analysts
|
— | -4.6% |
|
ALKT
Alkami Technology
|
Aug 01, 2024 | BUY |
Strong Buy
+81.4% avg upside
15 analysts
|
$38.00
158.84% Upside
|
-53.1% |
|
SPIR
Spire Global
|
Jul 18, 2024 | BUY |
Strong Buy
-18.4% avg upside
12 analysts
|
— | +37.8% |
|
OABI
OmniAb
|
Mar 21, 2024 | BUY |
Strong Buy
+249.1% avg upside
10 analysts
|
$10.00
327.37% Upside
|
-66.0% |
|
CSBR
Champions Oncology
|
Oct 16, 2023 | BUY |
Strong Buy
+34.6% avg upside
6 analysts
|
— | +4.0% |
|
ISPC
iSpecimen
|
Sep 13, 2023 | BUY |
Strong Buy
+64.1% avg upside
3 analysts
|
— | -85.2% |
|
FSLY
Fastly
|
Aug 18, 2023 | BUY |
Buy
+79.5% avg upside
25 analysts
|
— | -63.3% |
|
INFU
InfuSystem Holdings
|
May 04, 2023 | BUY |
Strong Buy
+62.1% avg upside
7 analysts
|
— | -42.8% |
|
ZG
Zillow Group Class A
|
May 03, 2023 | BUY |
Buy
+95.2% avg upside
45 analysts
|
$58.00
78.56% Upside
|
+63.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.